Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2025-12-27 @ 2:50 AM
Study NCT ID:
NCT01056393
Status:
COMPLETED
Last Update Posted:
2018-07-12
First Post:
2010-01-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Investigator-Sponsored Protocol - Continued Use of Ibalizumab
Sponsor:
Kaiser Permanente
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-11
Start Date Type:
None
Primary Completion Date:
2016-12-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12-15
Completion Date Type:
ACTUAL
First Submit Date:
2010-01-22
First Submit QC Date:
None
Study First Post Date:
2010-01-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-04-13
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2018-07-10
Last Update Post Date:
2018-07-12
Last Update Post Date Type:
ACTUAL